Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials

Table 2

Follow-up of patients treated with BM-MNCs.

	All ()	Spanish trial ()	Brazilian trial ()
Death	—	—	—	—
Stroke	—	—	—	—
MI	—	—	—	—
Infection	4 (18.2%)	4 (40%)	0 (0%)
SICH	—	—	—	—
Allergic reaction	—	—	—	—
Tumors	—	—	—	—
Seizure	7 (31.8%)	2 (20%)	5 (41.7%)	0.38
NIHSS 30	9.0 [6.0–12.0]	9.0 [7.0–13.0]	10.0 [5.2–12.0]	0.80
NIHSS 90	6.5 [4.7–11.2]	6.5 [5.7–11.7]	7.5 [4.0–11.7]	0.77
NIHSS 180	6.0 [4.0–10.2]	6.0 [3.7–11.2]	8.0 [4.2–10.7]	0.67
mRS ≤ 2 30	3 (13.6%)	1 (10%)	2 (16.7%)	0.99
mRS ≤ 2 90	5 (22.7%)	1 (10%)	4 (33.3%)	0.32
mRS ≤ 2 180	5 (22.7%)	2 (20%)	3 (25%)	0.99

.